Corrigendum to: “Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis”, [Biomed. Pharmacother., 161; (2023): 114472]

Corrigendum to: “Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis”, [Biomed. Pharmacother., 161; (2023): 114472]

Bibliographic Details
Main Authors:	Liang Shan, Fengling Wang, Dandan Zhai, Xiangyun Meng, Jianjun Liu, Xiongwen Lv
Format:	Article
Language:	English
Published:	Elsevier 2023-06-01
Series:	Biomedicine & Pharmacotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S0753332223004201

Similar Items

Matrix metalloproteinases induce extracellular matrix degradation through various pathways to alleviate hepatic fibrosis
by: Liang Shan, et al.
Published: (2023-05-01)

Corrigendum to “Neopetroside-B alleviates doxorubicin-induced cardiotoxicity via mitochondrial protection” [Biomed. Pharmacother. 165 (2023) 115232]
by: Chang Shin Yoon, et al.
Published: (2023-12-01)

Retraction notice to “Salidroside alleviates cigarette smoke-induced COPD in mice” [Biomed. Pharmacother. 86 (2017) 155–161]
by: Fen Luo, et al.
Published: (2023-04-01)

Corrigendum to “New insights about the PDGF/PDGFR signaling pathway as a promising target to develop cancer therapeutic strategies” [Biomed. Pharmacother. 161 (2023) 114491]
by: Pratibha Pandey, et al.
Published: (2023-11-01)

Corrigendum to “Valproate, divalproex, valpromide: Are the differences in indications justified?” [Biomed. Pharmacother., 158 (2023) 114051]
by: Clément Delage, et al.
Published: (2023-12-01)

Corrigendum to “Steatosis in metabolic diseases: A focus on lipolysis and lipophagy” [Biomed. Pharmacother. 160 (2023) 114311]
by: Xingtao Zhao, et al.
Published: (2023-07-01)

Corrigendum to “The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy” Biomed. Pharmacother. 165 (2023) 114893
by: Shuo Yuan, et al.
Published: (2024-02-01)

Corrigendum to “The potential molecular pathways of astragaloside-IV in colorectal cancer: A systematic review” [Biomed. Pharmacother. 167 (2023) 115625]
by: Tang Ziyang, et al.
Published: (2023-12-01)

Corrigendum to “Antidiabetic and antioxidant activities of Mitragyna speciosa (kratom) leaf extract in type 2 diabetic rats” [Biomed. Pharmacother. 162 (2023) 114689]
by: Pengpeng Zhang, et al.
Published: (2023-08-01)

Corrigendum to “Effects of oligonol on the submandibular gland in ovariectomized rats” [Biomed. Pharmacother. 141 (2021) 111897]
by: Jeong Hun Kim, et al.
Published: (2023-09-01)

Corrigendum to “Emerging strategy for the treatment of urothelial carcinoma: Advances in antibody-drug conjugates combination therapy” Biomed. Pharmacother. 171 (2024) 116152
by: Xiangyun You, et al.
Published: (2024-04-01)

Corrigendum to “Insights into the implementation of Fibronectin 1 in the cartilage tissue engineering” [Biomed. Pharmacother. 148 (2022) 112782]
by: Murad Alahdal, et al.
Published: (2022-09-01)

Corrigendum to “Discussing pathologic mechanisms of Diabetic retinopathy & therapeutic potentials of curcumin and β-glucogallin in the management of Diabetic retinopathy” Biomed. Pharmacother. 169 (2023) 115881
by: Manni Rohilla, et al.
Published: (2024-01-01)

Corrigendum to “Tegaserod maleate exhibits antileukemic activity by targeting TRPM8” [Biomed. Pharmacother. 154 (2022) 113566]
by: Xiaoling Xie, et al.
Published: (2023-10-01)

Corrigendum to: “Mitoquinone ameliorated airway inflammation by stabilizing β-catenin destruction complex in a steroid-insensitive asthma model” [Biomed. Pharmacother. vol. 162 (2023) 114680]
by: Junwen Huang, et al.
Published: (2023-09-01)

Matrix Metalloproteinases
by: S Sahitya, et al.
Published: (2010-01-01)

Erratum to alkaloids in commercial preparations of California poppy – Quantification, intestinal permeability and microbiota interactions [Biomed. Pharmacother. 166 (2023) 115420]
by: Antoine Chauveau, et al.
Published: (2023-11-01)

Corrigendum to “Danggui Shaoyao San ameliorates the lipid metabolism via the PPAR signaling pathway in a Danio rerio (zebrafish) model of hyperlipidemia” [Biomed. Pharmacother. 168 (2023) 115736]
by: Yuke Wang, et al.
Published: (2024-01-01)

Matrix Metalloproteinases Inhibitors in Cancer Treatment: An Updated Review (2013–2023)
by: Shriefa Almutairi, et al.
Published: (2023-07-01)

Expression of matrix metalloproteinase-2 in the extracellular matrix of osseointegrated and diseased implants
by: Ghada I Al-Duboni
Published: (2014-02-01)

MATRIX METALLOPROTEINASES AND TISSUE INHIBITORS OF MATRIX METALLOPROTEINASES DURING PREGNANCY AND DELIVERY
by: Yu. V. Korenovsky, et al.
Published: (2012-09-01)

Fractional Excretion of Survivin, Extracellular Matrix Metalloproteinase Inducer, and Matrix Metalloproteinase 7 in Children with Chronic Kidney Disease
by: Agnieszka Bargenda, et al.
Published: (2016-07-01)

Matrix metalloproteinases in cancer.
by: Itoh, Y, et al.
Published: (2002)

Matrix Metalloproteinases and Glaucoma
by: Moo Hyun Kim, et al.
Published: (2022-09-01)

Matrix metalloproteinases in oral cancer: A catabolic activity on extracellular matrix components
by: Vidya G Doddawad, et al.
Published: (2023-01-01)

Matrix metalloproteinase-induced cervical extracellular matrix remodelling in pregnancy and cervical cancer
by: Emmanuel Amabebe, et al.
Published: (2022-08-01)

Retraction notice to “Corrigendum to 'mPEG-b-P(Glu-co-Phe) nanoparticles increase gastric retention time and gastric ulcer treatment efficacy of 20(S)-ginsenoside Rg3' [Biomed. Pharmacother. 146 (2022) 112608]” [Biomed. Pharmacother. 152 (2022) 113213]
by: Lanqing Cao, et al.
Published: (2023-04-01)

Matrix metalloproteinases-9 and tissue inhibitor of matrix metalloproteinases-1 in sarcoidosis patients
by: Ivanišević Jasmina, et al.
Published: (2017-01-01)

Corrigendum to “Sacubitril/valsartan combination enhanced cardiac glycophagy and prevented the progression of murine diabetic cardiomyopathy” [Biomed. Pharmacother. 153 (2022) 113382]
by: Dina Salem Abdelaziz Elshenawy, et al.
Published: (2022-12-01)

‘Corrigendum to “Resveratrol inhibits proliferation, migration and invasion via Akt and ERK1/2 signaling pathways in renal carcinoma cells” [Biomed. Pharmacother. 98 (2018) 36–44]’
by: Yuwan Zhao, et al.
Published: (2022-09-01)

Corrigendum to “Paeonia lactiflora Pallas extract alleviates Antibiotics and DNCB-induced atopic dermatitis symptoms by suppressing inflammation and changing the gut microbiota composition in mice” [Biomed. Pharmacother. 154 (2022) 113574]
by: Seo Yeon Lee, et al.
Published: (2023-09-01)

Corrigendum to “Azithromycin induces read-through of the nonsense Apc allele and prevents intestinal tumorigenesis in C3B6F1 ApcMin/+ mice” [Biomed. Pharmacother. 164 (2023) 114968]
by: Ryoko Semba, et al.
Published: (2023-09-01)

Corrigendum: Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
by: Shaheen E. Lakhan, et al.
Published: (2018-04-01)

Agonist-Biased Signaling via Matrix Metalloproteinase-9 Promotes Extracellular Matrix Remodeling
by: Bessi Qorri, et al.
Published: (2018-08-01)

Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis.
by: Takwi Nkyimbeng, et al.
Published: (2013-01-01)

Corrigendum to “Ferroptosis: A new view on the prevention and treatment of diabetic kidney disease with traditional Chinese medicine” Biomed. Pharmacother. 170 (2024) 115952
by: Yu Chen, et al.
Published: (2024-01-01)

Corrigendum to “vanillic acid attenuates effects of transient bilateral common carotid occlusion and reperfusion in rats” [Biomed. Pharmacother. 96 (2017) 667–674]
by: Seyed Esmaeil Khoshnam, et al.
Published: (2023-09-01)

Corrigendum to “Magnolol alleviates Alzheimer's disease-like pathology in transgenic C. elegans by promoting microglia phagocytosis and the degradation of beta-amyloid through activation of PPAR-γ” [Biomed. Pharmacother. 124 (2020) 109886]
by: Zhishen Xie, et al.
Published: (2023-12-01)

Corrigendum to “Bone marrow mesenchymal stem cells alleviate the daunorubicin-induced subacute myocardial injury in rats through inhibiting infiltration of T lymphocytes and antigen-presenting cells” [Biomed. Pharmacother. 121 (2020) 109157]
by: Qiuru Chen, et al.
Published: (2023-08-01)

Progress in matrix metalloproteinase research.
by: Murphy, G, et al.
Published: (2008)